Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non–Small Cell Lung Cancer
Author:
Affiliation:
1. Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia
2. Division of Hematology/Oncology, Lankenau Medical Center, Wynnewood, Pennsylvania
Publisher
American Medical Association (AMA)
Subject
Oncology,Cancer Research
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2738063/jamaoncology_bauml_2019_oi_190036.pdf
Reference26 articles.
1. Is there an oligometastatic state in non-small cell lung cancer? a systematic review of the literature.;Ashworth;Lung Cancer,2013
2. Oligometastases revisited.;Weichselbaum;Nat Rev Clin Oncol,2011
3. An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non–small-cell lung cancer.;Ashworth;Clin Lung Cancer,2014
4. Radical treatment of synchronous oligometastatic non–small cell lung carcinoma (NSCLC): patient outcomes and prognostic factors.;Griffioen;Lung Cancer,2013
5. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non–small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.;Gomez;Lancet Oncol,2016
Cited by 212 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Surgery for oligometastatic non–small cell lung cancer;The Journal of Thoracic and Cardiovascular Surgery;2024-02
2. Role of radiotherapy in the management of brain oligometastases;Cancer/Radiothérapie;2024-02
3. Radiotherapy in the management of synchronous metastatic lung cancer;Cancer/Radiothérapie;2024-02
4. Aggressive Local Ablative Radiotherapy Mitigates Progression Risk in Oligometastatic Lung Adenocarcinoma;Cancer Research and Treatment;2024-01-15
5. Cachexia and Sarcopenia in Oligometastatic Non-Small Cell Lung Cancer: Making a Potential Curable Disease Incurable?;Cancers;2024-01-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3